SNAP-8 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of SNAP-8 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF092025042

Key analytical results include:

• Assay Content: 12.09 mg
• Identification – Retention Time: 0.986
• Identification – Spectrum: 990
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: detected but below 0.01 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

SNAP-8 is a synthetic peptide research compound frequently studied in controlled laboratory environments investigating peptide-mediated cellular signalling and protein interaction pathways.

The compound is derived from fragments of the SNARE complex protein SNAP-25 and is commonly examined in experimental models exploring peptide interactions with cellular communication systems.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, SNAP-8 has become a widely referenced compound in experimental peptide signalling research models.

Compound Overview

SNAP-8 is a synthetic octapeptide analogue derived from the N-terminal end of the SNAP-25 protein involved in cellular vesicle fusion mechanisms.

The SNAP-25 protein forms part of the SNARE protein complex responsible for mediating vesicle docking and membrane fusion in cellular communication systems.

Research involving SNAP-8 commonly examines its interaction with SNARE-related pathways and peptide-mediated cellular signalling mechanisms.

Due to its defined molecular structure and stable peptide profile, SNAP-8 is widely utilised in laboratory environments investigating protein interaction pathways and peptide-mediated signalling networks.

Historical Background and Scientific Context

Scientific research into vesicle fusion and cellular communication mechanisms expanded rapidly during the late twentieth century as molecular biology techniques advanced.

During this period the SNARE protein complex was identified as a key component responsible for vesicle docking and membrane fusion processes within cells.

Researchers subsequently began developing synthetic peptide fragments derived from SNARE-related proteins to study protein interaction dynamics and cellular signalling systems.

SNAP-8 emerged as one of these synthetic peptide fragments used in experimental models examining protein interaction pathways and cellular communication networks.

Mechanistic Focus in Research

Within experimental laboratory settings, SNAP-8 is commonly studied in relation to peptide-mediated signalling and protein interaction pathways.

Research investigations commonly explore the compound in experimental models examining:

• SNARE complex interaction dynamics
• Protein-mediated vesicle fusion mechanisms
• Peptide signalling pathway modelling
• Intracellular communication networks
• Comparative peptide interaction research
• Molecular protein interaction studies
• Cellular regulatory signalling pathways

These experimental models allow scientists to investigate molecular signalling mechanisms that influence cellular communication and regulatory processes.

Research Applications

In controlled research environments, SNAP-8 may be utilised in experimental models designed to explore protein interaction pathways and peptide signalling mechanisms.

Examples of research applications include:

• Protein interaction studies
• Peptide signalling pathway investigation
• SNARE complex interaction analysis
• Molecular communication network modelling
• Comparative peptide compound evaluation
• Intracellular regulatory pathway research
• Controlled in vitro peptide studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Independently analysed by Liquilabs s.r.o. Czechia
• Greater than 99.8 percent purity confirmed by COA
• Assay content verified at 12.09 mg
• Endotoxins below 0.01 EU per mg
• No detectable heavy metals or microbial contamination
• SNAP-derived neuropeptide analogue for research use
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.